

| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 474.37 |
| Log P | RDKit | 1.23 |
| Topological polar surface area (Å2) | RDKit | 208.12 |
| Number of hydrogen bond acceptors | RDKit | 10 |
| Number of hydrogen bond donors | RDKit | 6 |
| Number of carbon atoms | RDKit | 22 |
| Number of heavy atoms | RDKit | 34 |
| Number of heteroatoms | RDKit | 12 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 2 |
| Stereochemical complexity | RDKit | 0.09 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 20 |
| Number of sp3 hybridized carbon atoms | RDKit | 2 |
| Shape complexity | RDKit | 0.09 |
| Number of rotatable bonds | RDKit | 11 |
| Number of aliphatic carbocycles | RDKit | 0 |
| Number of aliphatic heterocycles | RDKit | 0 |
| Number of aliphatic rings | RDKit | 0 |
| Number of aromatic carbocycles | RDKit | 2 |
| Number of aromatic heterocycles | RDKit | 0 |
| Number of aromatic rings | RDKit | 2 |
| Total number of rings | RDKit | 2 |
| Number of saturated carbocycles | RDKit | 0 |
| Number of saturated heterocycles | RDKit | 0 |
| Number of saturated rings | RDKit | 0 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 2 |

| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 1 |
| Lipinski’s rule of 5 filter | RDKit | Passed |
| Number of Ghose filter violations | RDKit | 0 |
| Ghose filter | RDKit | Passed |
| Veber filter | RDKit | Bad |
| Pfizer 3/75 filter | RDKit | Good |
| GSK 4/400 filter | RDKit | Bad |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.172219 |

| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.11 |
| Solubility class [ESOL] | SwissADME | Soluble |
| Solubility class [Silicos-IT] | SwissADME | Soluble |
| Blood Brain Barrier permeation | SwissADME | No |
| Gastrointestinal absorption | SwissADME | Low |
| Log Kp (Skin permeation, cm/s) | SwissADME | -7.77 |
| Number of PAINS structural alerts | SwissADME | 1 |
| Number of Brenk structural alerts | SwissADME | 3 |
| CYP1A2 inhibitor | SwissADME | No |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | Yes |

| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_000966 | ENSG00000116044 | NFE2L2 | 4780 | NPASS |
| TAR_EXP_000157 | ENSG00000213341 | CHUK | 1147 | ChEMBL |
| TAR_EXP_001810 | ENSG00000067955 | CBFB | 865 | NPASS |
| TAR_EXP_001569 | ENSG00000173757 | STAT5B | 6777 | ChEMBL, NPASS |
| TAR_EXP_000390 | ENSG00000142208 | AKT1 | 207 | ChEMBL |
| TAR_EXP_001568 | ENSG00000168610 | STAT3 | 6774 | ChEMBL, NPASS |
| TAR_EXP_000503 | ENSG00000161905 | ALOX15 | 246 | NPASS |
| TAR_EXP_001621 | ENSG00000141510 | TP53 | 7157 | NPASS |
| TAR_EXP_001567 | ENSG00000115415 | STAT1 | 6772 | ChEMBL, NPASS |
| TAR_EXP_001362 | ENSG00000173039 | RELA | 5970 | ChEMBL |
| TAR_EXP_001554 | ENSG00000291971 | SRC | 6714 | ChEMBL, NPASS |
| TAR_EXP_001378 | ENSG00000143365 | RORC | 6097 | NPASS |
| TAR_EXP_000676 | ENSG00000072506 | HSD17B10 | 3028 | ChEMBL, NPASS |
| TAR_EXP_001206 | ENSG00000042088 | TDP1 | 55775 | NPASS |
| TAR_EXP_000706 | ENSG00000291796 | APEX1 | 328 | NPASS |
| TAR_EXP_000755 | ENSG00000104365 | IKBKB | 3551 | ChEMBL |
| TAR_EXP_000759 | ENSG00000169429 | CXCL8 | 3576 | NPASS |
| TAR_EXP_000970 | ENSG00000100906 | NFKBIA | 4792 | ChEMBL |
| TAR_EXP_000822 | ENSG00000182866 | LCK | 3932 | ChEMBL, NPASS |